Peptide record

TPDB25731

Antibacterial Antiviral standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB25731
Antibacterial Antiviral
Anti-infective peptides
Peptipedia DRAVP 2.0
standard
No
A 16-aa standard-residue multi-activity (Antibacterial and Antiviral) peptide sequence curated from Peptipedia and DRAVP 2.0, with an available 3D structural model.
Sequence
SRDKHEEHEKENDRGQ
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C78H124N30O32
ACILMFPTWYV
E
1994.02
5.34
6
6
0
-2
6.85
-3.275
0.00
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
0
A
2
R
1
N
2
D
0
C
4
E
1
Q
1
G
2
H
0
I
0
L
2
K
0
M
0
F
0
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 1 D: 2 C: 0 E: 4 Q: 1 G: 1 H: 2 I: 0 L: 0 K: 2 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
16 reviewed residue count
C78H124N30O32 sequence-only estimate (linear, free termini)
1994.02 sequence-only estimate (linear, free termini)
5.34 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
6.85 sequence-only estimate (linear, free termini)
-3.275 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0